echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Broad Pharma plans to take stake in Belgian company to introduce mRNA vaccine technology

    Broad Pharma plans to take stake in Belgian company to introduce mRNA vaccine technology

    • Last Update: 2020-06-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    According to the announcement, eTheRNA is a clinical-stage mRNA (ribonucleic acid) new vaccine technology company founded in 2013 by Professor Kris Thielemans, a renowned immunologist from the Free University of Brussels, and other partners, and has been granted an exclusive global license for VUB's TriMix-related technologythe deal is completed, BroadPharma will receive about 13% of eTheRNA's Class B preferred shares and a board seatIn accordance with the terms of the strategic cooperation, the cooperation includes the introduction of eTheRNA's mRNA production technology, independent research and development, production and commercialization activities in related fields, and the acquisition of the exclusive development and commercialization rights of eTheRNA in research projects in ChinamRNA technology is a new generation of vaccine technology that has emerged in recent years, and it does not need actual samples of viruses or their proteins to produce nucleic acids (drugs/vaccines) with genetic codes that instruct the body's own cells to synthesize certain proteins from viruses to trigger an immune responseTherefore, the advantage of mRNA vaccine is that the preparation step is simple, the development and production cycle is short, and the response to epidemic severity can be fasterbut so far, the field of mRNA vaccine treatment is in the early stage of global research and development, the world's fast-growing companies are mainly in the clinical phase I and Phase II research stage, has not yet formed a clear leading enterprise advantageSource: Broad Medicine Bulletin
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.